Mutual interaction of kisspeptin, estrogen and bone morphogenetic protein-4 activity in GnRH regulation by GT1-7 cells by Terasaka, Tomohiro et al.
                             Elsevier Editorial System(tm) for Molecular and Cellular Endocrinology 
                                  Manuscript Draft 
 
 
Manuscript Number: MCE-D-13-00008R1 
 
Title: Mutual interaction of kisspeptin, estrogen and bone morphogenetic protein-4 activity in GnRH 
regulation by GT1-7 cells.  
 
Article Type: Research Paper 
 
Keywords: BMP, estradiol, GnRH, GPR54, kisspeptin, and MAPK 
 
Corresponding Author: Prof. Fumio Otsuka, M.D., Ph.D. 
 
Corresponding Author's Institution: Okayama University Graduate School of Medicine, Dentistry and 
Pharmaceutical Sciences 
 
First Author: Tomohiro Terasaka, M.D. 
 
Order of Authors: Tomohiro Terasaka, M.D.; Fumio Otsuka, M.D., Ph.D.; Naoko Tsukamoto, M.D.; Eri 
Nakamura, M.D.; Kenichi Inagaki, M.D.; Kishio Toma, M.D.; Kanako Ogura-Ochi, M.D.; Christine 
Glidewell-Kenney, Ph.D.; Mark A Lawson, Ph.D.; Hirofumi Makino, M.D., Ph.D. 
 
Abstract: Reproduction is integrated by interaction of neural and hormonal signals converging on 
hypothalamic neurons for controlling gonadotropin-releasing hormone (GnRH).  Kisspeptin, the 
peptide product of the kiss1 gene and the endogenous agonist for the GRP54 receptor, plays a key role 
in the regulation of GnRH secretion.  In the present study, we investigated the interaction between 
kisspeptin, estrogen and BMPs in the regulation of GnRH production by using mouse hypothalamic 
GT1-7 cells.  Treatment with kisspeptin increased GnRH mRNA expression and GnRH protein 
production in a concentration-dependent manner.  The expression levels of kiss1 and GPR54 were not 
changed by kisspeptin stimulation.  Kisspeptin induction of GnRH was suppressed by co-treatment 
with BMPs, with BMP-4 action being the most potent for suppressing the kisspeptin effect.  The 
expression of kisspeptin receptor, GPR54, was suppressed by BMPs, and this effect was reversed in the 
presence of kisspeptin.  It was also revealed that BMP-induced Smad1/5/8 phosphorylation and Id-1 
expression were suppressed and inhibitory Smad6/7 was induced by kisspeptin.  In addition, estrogen 
induced GPR54 expression, while kisspeptin increased the expression levels of ERα and ERβ, 
suggesting that the actions of estrogen and kisspeptin are mutually enhanced in GT1-7 cells.  Moreover, 
kisspeptin stimulated MAPKs and AKT signaling, and ERK signaling was functionally involved in the 
kisspeptin-induced GnRH expression.  BMP-4 was found to suppress kisspeptin-induced GnRH 
expression by reducing ERK signaling activity.  Collectively, the results indicate that the axis of 
kisspeptin-induced GnRH production is bi-directionally controlled, being augmented by an interaction 
between ERα/β and GPR54 signaling and suppressed by BMP-4 action in GT1-7 neuron cells. 
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Response to Reviewer #1: 
 
Reviewers' comments: 
Reviewer #1: The paper by Terasaka et al. examines the mutual interaction of 
kisspeptin, estrogen and BMP-4 in the regulation of GnRH production in GT1-7 
cells. 
The paper is well written and the results are sound. My major area of concern is 
with regards to the interpretation of results. These concerns are outlined below. 
 
... Answer: 
We appreciate the reviewer’s comments on our manuscript.  The comments 
provided by the reviewer were very important to further discuss and reconsider 
our present data.  According to the reviewer’s comments and suggestions, we 
added new data and thoroughly revised the manuscript.  Please refer to our 
revised manuscript.  
 
1) What is the physiological relevance of GT1-7 cells? The authors state that 
these cells express Kiss1, GPR54, ERa, ERb and GnRH mRNA making them 
unlike any neuronal population in an in vivo setting. GnRH neurons do not 
express Kiss1 and do not express ERa. Thus, one must be extremely cautious 
when making conclusions using this cellular model. The authors state "The 
expression of kiss1, GPR54 and ERs, including ER? and ER?, in GT1-7 cells 
implied that the functional kisspeptin-ER system exists as an autocrine 
mechanism for GnRH secretion" Such a statement (while true in regards to the 
data) can be wildly misleading as it could imply to GnRH secretion in animals. 
The authors should carefully revise their document to account for this. 
 
… Answer 1) 
We agree.  The physiological relevance of utilizing GT1-7 cells is critical for this 
study.  At present, this cell model is the closest physiologically to GnRH neurons 
in vivo, although, as with any cell line, its use and conclusions drawn from it must 
be considered with caution.  Estrogens influence the GnRH neuronal network to 
modulate the final output of GnRH into the median eminence in females.  To 
know the detailed mechanism by which estrogen exerts positive and negative 
feedback effects, we utilized the GT1-7 cell line.  Immortalized GnRH-producing 
GT1-7 cells are valuable for studying the molecular biology of GnRH neurons.  
Both GnRH neurons and GT1-7 cells express GPR54, ER and the estrogen 
membrane receptor GPR30.  The cells differ from confirmed observations in 
vivo in the expression of ER and kisspeptin.  We focused on the action of 
GPR54 and report the interaction with BMPs, which are also expressed in the 
hypothalamus.  Although we also examined the action of estrogen, it is not clear 
if its action is mediated by GPR30, ER or ER.  As the referee commented, our 
findings may not fully translate to an in vivo model, but they do formulate 
hypotheses that can eventually be tested.  The inability to detect ER in native 
GnRH neurons has been well documented (Herbison and Pape, 2001; Herbison, 
2008), whereas kiss1 neurons predominantly express ER with a modest 
fraction expressing ER (Smith et al., 2005a; Smith et al., 2005b), suggesting 
*Revision Notes
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that kiss1 neurons mediate estrogen actions for GnRH secretion (Pinilla et al., 
2012).  To avoid confusion regarding the data for GT1-7 cells in terms of the 
physiology of GnRH regulation, we amended the discussion including the 
sentence stating "The expression of kiss1, GPR54 and ERs, including ER and 
ER, in GT1-7 cells implied that the functional kisspeptin-ER system exists as an 
autocrine mechanism for GnRH secretion."  In the present study, we also 
focused on interaction of the BMP system and ER action that is linked to 
hypothalamic GnRH production.  Regarding this interaction between BMP and 
ER, we carefully interpreted the data obtained from the cell line of GT1-7 in the 
discussion and focus on GPR54 and BMP receptor action on GnRH gene 
expression and secretion, not on kisspeptin expression.  The point the referee 
suggested here is very important for readers.  We thoroughly amended the 
discussion in the revised manuscript.  We appreciate the referee’s comments.   
 
2) The authors show an effect of estradiol on GT1-7 cells. In the paper no attempt 
is made to explain which of these receptors (or both) is mediating the estrogen 
effect. This is again important, as GnRH neurons do not posses ERa. In the 
discussion (and Figure 5) the authors simply state regulation by ER, without 
discriminating which receptor. This needs to be reconciled. 
 
… Answer 2) 
We agree.  GT1-7 neuron cells express both ER and ER (as shown in the 
lower panel (Otani et al., 2009)), unlike native GnRH neurons, which express only 
ER.  Based on our results including results of our previous study using GT1-7 
cells, we consider that both ER and ER are involved in the process of GnRH 
regulation via a combination of kisspeptin, BMP-4 and estrogen.  It is actually 
difficult to compare the absolute expression levels of both ERs, however, based 
on Western blots, we speculate that ER expression is more abundant than ER 
in GT1-7 cells.  We revised the discussion and Fig. 5 accordingly.  Thank you 
for your comment. 
 
GT1-7 cells (1 × 10
5
 cells/ml) were treated with BMP-2, 
-4, -6 and -7 (100 ng/ml) in serum-free condition.  After 
24-h culture, cells were lysed and subjected to 
SDS-PAGE/immunoblotting (IB) analysis using 
anti-ER, anti-ER and anti-actin antibodies.  The 
results shown are representative of those obtained 
from three independent experiments. (Otani and 
Otsuka et al. J Endocrinol 203: 87, 2009) 
 
 
 
 
 
 
3) Is BMP expressed in neurons in vivo? Is it expressed in GnRH neurons? 
Kisspeptin neurons? Such information would strengthen the relevance of the 
data. 
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… Answer 3) 
We agree.  In vivo information regarding BMP expression is very important.  
The interaction of neural and hormonal signals including BMPs and kisspeptin 
may integrate the neuronal activity for GnRH secretion.  However, information 
regarding BMPs in the hypothalamus is limited.  The neuro-regulatory factors 
TGF-1 and TGF- secreted by astrocytes may be candidates for modulation of 
GnRH secretion.  Given the findings that several BMPs elicit a neurotropic 
capacity for dopaminergic neurons in cooperation with other members of the 
TGF- superfamily through glial cells, hypothalamic GnRH production and/or 
secretion may be functionally associated with BMP activity in the neural network.  
However, in order to clarify expression of the BMP system including BMP ligands 
and receptors in the hypothalamus, we additionally examined the mRNA 
expression of BMP system components by RT-PCR.  The key BMP ligands 
(BMP-2, -4, -6 and -7) and receptor components (ALK-2, -3, -4, -6, BMPRII, 
ActRIIA and IIB) were clearly expressed in hypothalamic tissues.  We added 
these data in new Fig. 1B in the revised manuscript.  Thank you for your 
important comments.    
 
4) The dose of kisspeptin used to elicit a GnRH response seem excessively high 
compared to other published manuscripts. Here the authors only saw effects at 
300 nM, 1 uM and higher.  In the referenced paper by Novaira et al (2009) 
greater stimulation was seen with only 1 nM. This leads to concerns over the 
viability of cells or the kisspeptin used. Can the authors comment? 
 
… Answer 4) 
Certainly, the GnRH responsiveness (detected by RIA and qPCR) by kisspeptin 
was weaker than that reported by Novaira et al. (Novaira et al., 2009).  Based on 
Navaira’s report, the response of GnRH production by GT1-7 cells was quickly 
but only transiently shown after 1-h to 4-h incubation with 1 nM kisspeptin.  In 
their study using GT1-7 cells, GnRH protein levels were increased approximately 
2-fold compared with the vehicle control.  In a study by Tonsfelt et al., 10 nM of 
kisspeptin was used for GT1-7 cells, resulting in a similar increase in the level of 
GnRH secretion by 2-3 fold for 30-h to 48-h of treatment (Tonsfeldt et al., 2011).  
In the present study, GnRH response was modest and increased up to 1.5 to 2 
fold after 24-h culture with 300-1000 nM of kisspeptin.  This effect was certainly 
weak but not too weak compared with those observed in the previous studies.  
This could be due to time-course (24 h) and serum-starvation (serum-free) 
conditions in our study.  Much earlier time points and serum inclusion in the 
medium might be suitable to see higher responsiveness of GnRH in response to 
exogenous kisspeptin.  However, in the present study, we focused on interaction 
of the BMP system and ER action that is linked to hypothalamic GnRH production.  
To clarify the interaction between BMP and a genomic effect of ER, it usually 
takes 24 to 48 h and serum contents in the medium often disturb the effect of 
BMPs as well as steroids.  Considering these points, we decided to use a 
24-hour culture condition with higher concentrations of kisspeptin and the data 
obtained were stable and reproducible.  We added discussion regarding the 
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differences in our treatment regime with that of others to assist the reader in 
interpretation of our data.  We appreciate your important comments.   
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Thank you for your review. 
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Response to Reviewer #2: 
 
Reviewers’ comments: 
Reviewer #2: This paper uses the immortalized GT1-7 cell line well characterized 
to investigate the interaction between kisspeptin, estrogen and BMPs in the 
regulation of GnRH production. 
The authors provide several lines of evidence that the axis of kisspeptin-induced 
GnRH production is controlled by opposite signaling pathways; one increased by 
an interaction between estrogen receptor and kisspeptin receptor, another 
suppressed by BMP-4 action. 
Molecular mechanisms are needed to support the physiological relevance of 
these experiments. 
 
The data are interesting but enthusiasm is reduced by the interpretation and 
robustness of the results. Specific issues are addressed below:  
 
… Answer: 
We appreciate the reviewer’s favorable comments on our manuscript.  The 
comments provided by the reviewer were very important to further discuss and 
reconsider our present data.  According to the reviewer’s comments and 
suggestions, we added new data and thoroughly revised the manuscript.  
Please refer to our revised manuscript.  
 
1. Fig. 1B. The crude values of GnRH release must be presented since the 
differences appear very low according to the representation (fold increase). 
 
… Answer 1: 
We agree.  We added the raw data of GnRH in the revised manuscript (Fig. 1C). 
 
2. Fig. 2 A and B. The effect of BMP-6 alone is not valid. 
 
… Answer 2: 
We agree.  There were mistakes in Fig. 2A and 2B.  We amended the figures in 
the revised manuscript.  Thank you for your comment.      
 
3. Fig. 3B. The data obtained using BMP-6 and -7 are not shown. Why?? 
 
… Answer 3: 
Based on the data in Fig. 2A, among BMP ligands we focused on the effects of 
BMP-4, which suppressed kisspeptin-induced GnRH expression by GT1-7 cells.  
As shown in Fig. 3B, Id-1 transcription induced by BMP-4, but not by BMP-2, was 
significantly suppressed by kisspeptin.  The Id-1 mRNA levels induced by 
BMP-6 and -7 were also reduced by co-treatment with kisspeptin.  We added 
these data in the revised manuscript.  Please refer to our revised Fig. 3B. 
 
4. Fig. 4. The western blots are very difficult to interpret. Quantitative values 
should be added. 
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… Answer 4: 
We agree.  We added the data regarding quantitative values of Western blots in 
the revised Fig. 4D.  The relative integrated density of each protein band was 
digitized, in which the phosphorylated levels were normalized by the total levels, 
and then the results were statistically analyzed and expressed as fold changes.  
Thank you for your comments.   
 
5. The estradiol effect in Fig 4B is only evaluated on the transcript. It is possible to 
measure the GnRH levels as in the Fig1. 
 
… Answer 5: 
We agree.  We have measured the protein levels of GnRH in the medium as well.   
As shown in the new Fig. 4B, treatment with estradiol (100 nM) suppressed 
GnRH mRNA levels after 24-h culture of GT1-7 cells.  In terms of the protein 
level, the same concentration of estradiol tended to reduce GnRH secretion for 
24-h culture, but significantly suppressed GnRH production after 48-h culture 
(new Fig. 4C).  It is informative for the readers to show the protein levels of 
GnRH in this study.  Thank you for your comments.   
 
6. A number of typographical errors should be corrected (Fig 1.).  
 
… Answer 6: 
We feel sorry for this point.  Again, we carefully checked up throughout the 
manuscript including figures.  Please refer to our revised manuscript. 
 
 
Thank you for your review. 
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ABSTRACT 1 
 2 
Reproduction is integrated by interaction of neural and hormonal signals 3 
converging on hypothalamic neurons for controlling gonadotropin-releasing 4 
hormone (GnRH).  Kisspeptin, the peptide product of the kiss1 gene and the 5 
endogenous agonist for the GRP54 receptor, plays a key role in the regulation 6 
of GnRH secretion.  In the present study, we investigated the interaction 7 
between kisspeptin, estrogen and BMPs in the regulation of GnRH production 8 
by using mouse hypothalamic GT1-7 cells.  Treatment with kisspeptin increased 9 
GnRH mRNA expression and GnRH protein production in a concentration-10 
dependent manner.  The expression levels of kiss1 and GPR54 were not 11 
changed by kisspeptin stimulation.  Kisspeptin induction of GnRH was 12 
suppressed by co-treatment with BMPs, with BMP-4 action being the most 13 
potent for suppressing the kisspeptin effect.  The expression of kisspeptin 14 
receptor, GPR54, was suppressed by BMPs, and this effect was reversed in the 15 
presence of kisspeptin.  It was also revealed that BMP-induced Smad1/5/8 16 
phosphorylation and Id-1 expression were suppressed and inhibitory Smad6/7 17 
was induced by kisspeptin.  In addition, estrogen induced GPR54 expression, 18 
while kisspeptin increased the expression levels of ER and ER, suggesting 19 
that the actions of estrogen and kisspeptin are mutually enhanced in GT1-7 20 
cells.  Moreover, kisspeptin stimulated MAPKs and AKT signaling, and ERK 21 
signaling was functionally involved in the kisspeptin-induced GnRH expression.  22 
BMP-4 was found to suppress kisspeptin-induced GnRH expression by 23 
reducing ERK signaling activity.  Collectively, the results indicate that the axis of 24 
Terasaka and Otsuka et al. 
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kisspeptin-induced GnRH production is bi-directionally controlled, being 1 
augmented by an interaction between ER/ and GPR54 signaling and 2 
suppressed by BMP-4 action in GT1-7 neuron cells.  (254 words) 3 
 4 
 5 
6 
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INTRODUCTION 1 
 2 
Reproduction is regulated by a complex interaction of neural and 3 
hormonal signals that converge on hypothalamic neurons responsible for the 4 
pulsatile secretion of gonadotropin-releasing hormone (GnRH) (Pinilla et al., 5 
2009).  Coordination of the GnRH impulse from the hypothalamus and the 6 
subsequent secretion of pituitary gonadotropins are critical for the central 7 
control of reproductive function (Pinilla et al., 2009).  The pattern of GnRH 8 
secretion is regulated by the intrinsic oscillatory activity of GnRH neurons and 9 
the integration of presynaptic inputs of various neurotransmitters such as 10 
kisspeptin and gonadotropin-inhibitory hormone (GnIH) (Tsutsui et al., 2010) 11 
and the feedback loop from gonadal steroids (Petersen et al., 2003).  12 
Immortalized GnRH-producing GT1-7 cells have proven to be a valuable tool to 13 
study the biology of GnRH neurons (Liposits et al., 1991; Wetsel et al., 1991).  14 
In females, estrogens act directly or indirectly on the GnRH neuronal network to 15 
modulate the final output of GnRH into the median eminence (Garcia-Galiano et 16 
al., 2012; Hameed et al., 2011).  However, the detailed mechanism by which 17 
estrogen exerts positive and negative feedback effects is still controversial.   18 
Progress has been made in elucidation of the indirect mechanism of 19 
estrogen-GnRH regulation following the discovery of kisspeptin.  Recently, an 20 
understanding of the physiological control of the reproductive axis has been 21 
advanced by identification of the essential role of kisspeptin.  Kisspeptins are 22 
products of the kiss1 gene and these peptides are derived from the plasma 23 
proteolytic cleavage of the 145-amino-acid gene product.  The kisspeptin 24 
Terasaka and Otsuka et al. 
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fragments commonly have a C-terminal decapeptide including Arg-Phe residues 1 
that are critical for the biological activity (Clements et al., 2001; Kotani et al., 2 
2001; Ohtaki et al., 2001).  Kisspeptin and its receptor, G-protein-coupled 3 
receptor 54 (GPR54), are key components in the regulation of GnRH secretion 4 
in humans and other mammals (Goodman and Lehman, 2012).  Kisspeptin is 5 
found in both the peripheral and central nervous systems.  In the periphery, 6 
kisspeptin has been identified in the testis, ovary, pituitary gonadotrope, 7 
pancreas, small intestine and placenta (Gaytan et al., 2009; Horikoshi et al., 8 
2003; Muir et al., 2001; Ohtaki et al., 2001; Richard et al., 2008).  In the central 9 
nervous system, both kiss1 mRNA and kisspeptin protein are abundantly 10 
expressed within the hypothalamus in the arcuate nucleus (ARC), anteroventral 11 
periventricular nucleus (AVPV) and periventricular nucleus (Gottsch et al., 12 
2004) in rodents.  Hypothalamic kiss1 mRNA is predominantly found in the 13 
infundibular nucleus, the equivalent of the ARC in primates (Rometo et al., 14 
2007).  Accumulated data have shown that central or systemic administration of 15 
kisspeptin increases GnRH and gonadotropin secretion in both prepubertal and 16 
adult animals, which is crucial for the neuroendocrine regulation of reproduction 17 
(Castellano et al., 2005; Funes et al., 2003; Pinilla et al., 2012; Seminara et al., 18 
2003; Tena-Sempere, 2006).  GPR54 is also critical for the integrity of 19 
reproductive activity, as shown in patients with idiopathic hypogonadotropic 20 
hypogonadism and in GPR54-knockout mice (de Roux et al., 2003; Funes et al., 21 
2003; Seminara et al., 2003).  22 
Bone morphogenetic proteins (BMPs), which belong to the transforming 23 
growth factor (TGF)- superfamily, were originally identified as active 24 
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components in bone extracts that are capable of inducing bone formation at 1 
ectopic sites.  Recent studies have shown that BMPs are crucial molecules in 2 
normal folliculogenesis by regulating gonadotropin-induced steroidogenesis and 3 
mitosis in ovarian granulosa cells (Otsuka, 2010; Otsuka et al., 2011; Shimasaki 4 
et al., 2004). The major regulatory process by BMPs in ovarian steroidogenesis 5 
is control of follicle-stimulating hormone (FSH)-receptor activity, leading to 6 
normal follicular development in the ovary.  It has also been reported that BMPs 7 
are involved in the regulation of various functions of the anterior pituitary 8 
including gonadotropin secretion (Otsuka and Shimasaki, 2002; Otsuka et al., 9 
2012; Otsuka, 2013; Takeda et al., 2007; Tsukamoto et al., 2010).  Bi-10 
directional communication between the ovary and central nervous system 11 
ensures that the neural signal for ovulation occurs at the time point when follicle 12 
maturation is completed.  The BMP system is also required for the early 13 
developmental stage of the hypothalamus for regulating cell identities in the 14 
neural tube (Liu and Niswander, 2005; Ulloa and Briscoe, 2007).   15 
We have reported expression of the BMP system including BMP type I 16 
and type II receptors in hypothalamic neuron GT1-7 cells (Otani et al., 2009).  In 17 
that study, it was found that BMPs modulate the suppressive effects of estrogen 18 
on GnRH production by regulating estrogen receptor (ER) expression and 19 
estrogen-induced MAPK signaling.  Interaction of the BMP system and ER 20 
action may be linked to hypothalamic GnRH production in an 21 
autocrine/paracrine fashion.  Hence, the BMP system plays a regulatory role in 22 
female reproduction not only by altering gonadotropin sensitivity in ovarian 23 
folliculogenesis but also by modulating the hypothalamo-pituitary-ovarian (HPO) 24 
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axis.  However, the direct effects of BMPs on hypothalamic GnRH production 1 
and secretion have yet to be elucidated.  Reproduction is regulated by mutual 2 
interaction of neural and hormonal factors that direct the production and 3 
secretion of GnRH.  In the present study, we investigated the effects of BMPs 4 
on GnRH production controlled by kisspeptin.  We uncovered a novel 5 
interaction between BMP-4, kisspeptin and estrogen, which is involved in the 6 
control of hypothalamic GnRH production and secretion by GT1-7 neuron cells. 7 
 8 
9 
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MATERIALS AND METHODS 1 
 2 
Reagents and supplies 3 
Dulbecco’s Modified Eagle’s Medium (DMEM), dimethylsulfoxide (DMSO), 4 
penicillin-streptomycin solution, human metastin (45-54) amide (kisspeptin-10), 5 
and 17-estradiol were purchased from Sigma-Aldrich Co. Ltd. (St. Louis, MO).  6 
Mouse hypothalamus total RNA was purchased from Clontech Laboratories, Inc. 7 
(Mountain View, CA).  Recombinant human BMP-2, -4, -6 and -7 were 8 
purchased from R&D Systems Inc. (Minneapolis, MN), the extracellular signal-9 
regulated kinase (ERK) inhibitor U0126 and p38-MAPK inhibitor SB203580 10 
were from Promega Corp. (Madison, WI), the stress-activated protein kinase/c-11 
Jun NH2-terminal kinase (SAPK/JNK) inhibitor SP600125 was from Biomol Lab. 12 
Inc. (Plymouth Meeting, PA), and the AKT inhibitor SH-5 was from Calbiochem 13 
(San Diego, CA).   14 
 15 
GT1-7 cell culture 16 
GT1-7 cells were kindly provided by Dr. Pamela L. Mellon, University of 17 
California, San Diego, CA.  The GT1-7 cells were maintained in DMEM 18 
supplemented with 10% fetal calf serum (FCS), penicillin and streptomycin 19 
(Sigma-Aldrich Corp.) at 37C in a 5% CO2 humidified atmosphere.  The culture 20 
medium was changed twice a week, and cultures were passaged at ~80% 21 
confluence.  Changes in cell morphology and growing conditions were carefully 22 
monitored under an inverted microscope.   23 
 24 
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Measurement of GnRH production 1 
To assess the effects of BMPs on GnRH protein synthesis, GT1-7 cells (2  105 2 
viable cells/ml) were cultured in 6-well plates with DMEM containing 10% FCS 3 
for 24 h.  The medium was then changed to serum-free DMEM and was 4 
subsequently treated with the indicated concentrations of kisspeptin.  After 24-h 5 
culture, the supernatant of the culture media was collected and stored at -80C 6 
until assay.  GnRH concentration (pg/ml) in the conditioned medium was 7 
determined by a radioimmunoassay as reported previously (Chappell et al., 8 
2003; Otani et al., 2009).  Briefly, 0.1-ml aliquots of each sample were 9 
incubated for 48 h with the GnRH antibody EL-14 at 4°C, after which time 10 
10,000 cpm sample of radio-iodinated GnRH (Amersham Pharmacia, 11 
Piscataway, NJ) was added.  Following ethanol precipitation of the bound 12 
fractions after 48-h incubation, radioactivity was detected by a gamma 13 
scintillation counter (Micromedic, Huntsville, AL), and standard curve analysis 14 
was performed at each assay.  The inter-assay variability and intra-assay 15 
variability in the radioimunoassay are 8.7% and 7.7%, respectively. 16 
 17 
RNA extraction, RT-PCR and quantitative real-time PCR analysis 18 
GT1-7 cells (2  105 viable cells/ml) were precultured in serum-free DMEM, and 19 
the cells were treated with indicated concentrations of kisspeptin in combination 20 
with BMPs, estradiol and various chemical inhibitors including U0126, 21 
SB203580, SP600125 and SH-5.  After 24-h culture, the medium was removed, 22 
and total cellular RNAs were extracted using TRIzol (Invitrogen Corp., 23 
Carlsbad, CA) and subsequently quantified by measuring absorbance at 260 24 
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nm and then stored at -80C until assay.  The expression of GnRH, kiss1, 1 
GPR54, ERs (ER and ER), BMP ligands (BMP-2, -4, -6 and -7), BMP type I 2 
(ALK-2, -3, -4 and -6) and type II (ActRIIA, ActRIIB and BMPRII) receptors, and 3 
Smads (Smad6 and 7) was detected by RT-PCR.  The extracted RNA (1 g) 4 
was subjected to a RT reaction using First-Strand cDNA Synthesis System 5 
(Invitrogen Corp.) with random hexamer (2 ng/l), reverse transcriptase (200 U) 6 
and deoxynucleotide triphosphate (dNTP; 0.5 mM) at 42C for 50 min and at 7 
70C for 10 min.  Subsequently, hot-start PCR was performed using MgCl2 (1.5 8 
mM), dNTP (0.2 mM) and Taq DNA polymerase (2.5 U) (Invitrogen Corp.).  9 
Oligonucleotides used for PCR were custom-ordered from Invitrogen Corp.  10 
PCR primer pairs were selected from different exons of the corresponding 11 
genes to discriminate PCR products that might arise from possible chromosome 12 
DNA contaminants.  The primer pairs for mouse BMP ligands, receptors, Id-1, 13 
Smads, and the house-keeping gene ribosomal protein-L19 (RPL19) were 14 
selected as we previously reported (Otani et al., 2009; Takeda et al., 2007; 15 
Tsukamoto et al., 2010).  For ERs, GnRH, kiss1 and GPR54 genes, the 16 
following sequences were used: ER, 1523-1543 and 1737-1757 from 17 
GenBank accession number NM_007956; ER, 701-721 and 1004-1024 from 18 
NM_010157; GnRH, 90-110 and 316-336 from BC116897; kiss1, 61-81 and 19 
328-352 from NM_178260; and GPR54, 1959-1980 and 2122-2144 from 20 
NM_053244.  Aliquots of the PCR products were electrophoresed on 1.5% 21 
agarose gels and visualized after ethidium bromide staining.  For the 22 
quantification of the receptors for BMP-4 (ALK-3 and BMPRII), ERs (ER and 23 
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ER), GnRH, GPR54, Id-1, kiss1, Smads (Smad6 and Smad7) and RPL19 1 
mRNA levels, real-time PCR was performed using LightCycler-FastStart DNA 2 
master SYBR Green I system (Roche Diagnostic Co., Tokyo, Japan) under 3 
each optimized condition of annealing at 59 to 63C with 4 mM MgCl2, following 4 
the manufacturer’s protocol.  Accumulated levels of fluorescence for each 5 
product were analyzed by the second derivative method after melting-curve 6 
analysis (Roche Diagnostic Co.), and then, following assay validation by 7 
calculating amplification efficiency of each amplicon, the expression levels of 8 
target genes were quantified on the basis of standard curve analysis for each 9 
product.  For each transcript, all treatment groups were quantified 10 
simultaneously in a single LightCycler run.  To correct for differences in RNA 11 
quality and quantity between samples, the expression levels of target gene 12 
mRNA were normalized by dividing the quantity of the target gene by the 13 
quantity of RPL19 in each sample.  The raw data of each target mRNA level 14 
(/RPL19) were statistically analyzed as indicated and are shown as fold 15 
changes in the figures.   16 
 17 
Western immunoblot analysis 18 
GT1-7 cells (1  105 viable cells/ml) were precultured in 12-well plates in serum-19 
free DMEM.  The cells were treated with BMPs (100 ng/ml) and kisspeptin (300 20 
nM) either alone or in combination with estradiol (100 nM).  After 15- and 60-21 
min stimulation indicated, cells were solubilized in 100 l RIPA lysis buffer 22 
(Upstate Biotechnology, Lake Placid, NY) containing 1 mM Na3VO4, 1 mM NaF, 23 
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2% SDS and 4% -mercaptoethanol.  The cell lysates were then subjected to 1 
SDS-PAGE/immunoblotting analysis as we previously reported (Otani et al., 2 
2009; Tsukamoto et al., 2010), using anti-phospho- and anti-total-extracellular 3 
signal-regulated kinase (ERK) 1/2 MAPK antibody (Cell Signaling Technology, 4 
Inc., Beverly, MA), anti-phospho- and anti-total-p38 MAPK antibody (Cell 5 
Signaling Technology, Inc.), anti-phospho- and anti-total-stress-activated 6 
protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK) MAPK antibody (Cell 7 
Signaling Technology, Inc.), anti-phospho- and anti-total-AKT antibody, anti-8 
phospho-Smad1/5/8 (pSmad1/5/8) antibody (Cell Signaling Technology, Inc.), 9 
and anti-actin antibody (Sigma-Aldrich Co. Ltd.).  The relative integrated density 10 
of each protein band was digitized by NIH image J 1.34s.  11 
 12 
Statistical analysis 13 
All results are shown as means  SEM of data from at least three separate 14 
experiments, each performed with triplicate samples.  The data were subjected 15 
to ANOVA or the unpaired t-test (StatView 5.0 software, Abacus Concepts, Inc., 16 
Berkeley, CA).  If differences were detected by ANOVA, Tukey-Kramer’s post 17 
hoc test was used to determine which means differed (StatView 5.0 software).  18 
P values < 0.05 were accepted as statistically significant. 19 
 20 
 21 
 22 
 23 
24 
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RESULTS 1 
 2 
First, expression of the kisspeptin system in GT1-7 cells was confirmed 3 
by RT-PCR.  As shown in Fig. 1A, in addition to GnRH expression, kiss1, 4 
GPR54, ER and ER were clearly expressed in mouse hypothalamic GT1-7 5 
neuron cells.  To clarify the existence of kisspeptin and BMP system in vivo, we 6 
examined the expression of these molecules in the mouse hypothalamus.  As 7 
shown in Fig. 1B, the GnRH-kisspepetin system, including GnRH, kiss1, 8 
GPR54, ER and ER, BMP ligands (BMP-2, -4, -6 and -7), BMP type I (ALK-2, 9 
-3, -4 and -6) and BMP type II (BMPRII, ActRIIA and ActRIIB), and inhibitory 10 
Smads (Smad6 and 7) were detected in the mouse hypothalamus.  Although 11 
kisspeptin expression is not demonstrated in GnRH neurons in vivo, GPR54 12 
expression is present and influences GnRH secretion and expression.  To 13 
examine the functional role of kisspeptin in GnRH production by GT1-7 cells, 14 
cells were treated with kisspeptin (0.1 to 1 M) and GnRH concentration in the 15 
serum-free medium was determined by RIA.  As shown in Fig. 1C, kisspeptin 16 
treatment significantly increased GnRH release in a concentration-dependent 17 
manner.  The mRNA level of GnRH was also increased by kisspeptin (0.01 to 3 18 
M) treatment (Fig. 1D), whereas the expression levels of kiss1 and GPR54 19 
were not altered by kisspeptin  (0.03 to 3 M) treatment (Fig. 1E).   20 
 Of note, the stimulating effects of kisspeptin on GnRH mRNA levels 21 
were suppressed by co-treatment with BMPs (100 ng/ml) including BMP-2, -4, -22 
6 and BMP-7 (Fig. 2A).  BMP-4 action was the most potent inhibitor of GnRH 23 
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induction by kisspeptin.  It was also revealed that the expression of the 1 
kisspeptin receptor, GPR54, was potently suppressed by treatment with BMP-2, 2 
-4, -6 and -7 (Fig. 2B).  Interestingly, the BMP actions that suppress GPR54 3 
expression were significantly reversed by co-treatment with kisspeptin (300 nM).   4 
To describe the mechanism by which kisspeptin interferes with the 5 
effects of BMPs, the downstream signals of BMP receptors, Smad1/5/8 6 
phosphorylation and Id-1 transcription, were examined (Fig. 3).  As shown in 7 
Fig. 3A, treatments with BMP-2 and -4 (100 ng/ml) readily stimulated 8 
Smad1/5/8 phosphorylation in GT1-7 cells; however, BMP-induced Smad1/5/8 9 
phosphorylation, in particular that induced by BMP-4, was suppressed by co-10 
treatment with kisspeptin (300 nM).  To confirm the effects of kisspeptin on BMP 11 
receptor signaling, Id-1 mRNA levels were examined by real-time PCR analysis.  12 
In accordance with the results of immunoblots for Smad1/5/8, Id-1 mRNA 13 
activation induced by BMP-2, -4, -6 and -7 (100 ng/ml) was suppressed by 14 
kisspeptin (300 nM) (Fig. 3B).  Of note, the suppressive effect of kisspeptin on 15 
BMP-2-induced Id-1 expression was less potent than that on Id-1 expression 16 
induced by BMP-4, -6 and -7.   17 
To investigate the molecular mechanism by which kisspeptin (300 nM) 18 
regulates BMP activities in GT1-7 cells, the expression changes in ALK-3 and 19 
BMPRII, which are major type I and type II receptors for BMP-2 and -4, 20 
respectively, were examined in the presence or absence of estradiol (100 nM).  21 
As shown in Fig. 3C, kisppeptin treatment had no effect on ALK-3 or BMPRII 22 
mRNA levels regardless of the presence of estradiol.  The effects on inhibitory 23 
Smads, including Smad6 and Smad7, were also examined.  As shown in Fig. 24 
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3D, mRNA levels of Smad6 and Smad7 were increased in the presence of 1 
BMP-2 and -4.  Kisspeptin treatment had no significant effect on Smad6 and 2 
Smad7 mRNA expression in the presence of BMP-2; however, it was notable 3 
that kisspeptin significantly increased Smad6 and Smad7 levels in the presence 4 
of BMP-4.  Thus, kisspeptin regulates BMP activity by increasing inhibitory 5 
Smads expression in GT1-7 cells.  6 
Next, the interaction between kisspeptin and estrogen action was studied.  7 
Treatment with kisspeptin (100 nM) significantly increased the expression levels 8 
of ER and ER mRNAs (Fig. 4A).  Treatment with estradiol (100 nM) 9 
suppressed GnRH mRNA expression (Fig. 4B, left) and GnRH protein levels in 10 
the media (Fig. 4C) by GT1-7 cells as a negative feedback effect, while 11 
estradiol significantly increased kisspeptin receptor GPR54 mRNA expression 12 
levels in GT1-7 cells (Fig. 4B, right).  These findings suggest that the actions of 13 
estrogen and kisspeptin are mutually enhanced in GT1-7 cells.  14 
We further investigated the underlying mechanism by which BMP-4 15 
suppressed kisspeptin-induced GnRH expression.  As shown in Fig. 4D, 16 
kisspeptin (300 nM) stimulated ERK and AKT phosphorylation and the actions 17 
of kisspeptin were enhanced in the presence of estradiol (100 nM), although it 18 
failed to increase P38 and JNK phosphorylation in GT1-7 cells.  As shown in 19 
Fig. 4E, treatment with chemical inhibitors for MAPKs and AKT, including 20 
U0126, SB203580, SP600125 and SH5 (1 to 10 M), revealed that kisspeptin-21 
induced GnRH mRNA expression was suppressed by the ERK inhibitor (U0126), 22 
suggesting that ERK signaling is functionally involved in the kisspeptin-induced 23 
GnRH expression.  As shown in Fig. 4F, BMP-4 treatment (100 ng/ml) was 24 
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found to suppress kisspeptin-induced ERK phosphorylation in GT1-7 cells.  It 1 
was thus thought that BMP-4 suppresses kisspeptin-induced GnRH production 2 
by inhibiting ERK activation. 3 
  4 
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DISCUSSION 1 
 2 
The mechanism by which estrogen acts on the GnRH regulatory system 3 
has yet to be clarified.  Direct actions on GnRH neurons as well as indirect 4 
actions through other linked neurons via trans-synaptic interaction seem to be 5 
involved in this machinery.  It was revealed that kisspeptin stimulated GnRH 6 
synthesis and the GnRH induction was suppressed by BMP-4 in mouse 7 
hypothalamic GT1-7 cells, suggesting the presence of a mutual balance 8 
between the actions of kisspeptin and BMP-4 for regulating GnRH (Fig. 5).  In 9 
this interaction, estrogen upregulated GPR54 expression, and kisspeptin, in turn, 10 
increased the expression levels of ER and ER in addition to the role of 11 
estrogen as a GnRH repressor of negative feedback.  On the other hand, 12 
GPR54 expression was suppressed by BMPs.  The suppressive effect of BMPs 13 
on GPR54 expression was reversed by kisspeptin via upregulation of inhibitory 14 
Smad6/7 expression.  Hence, in GT1-7 neuron cells, the axis of kisspeptin-15 
induced GnRH production is bi-directionally controlled, being augmented by the 16 
estrogen-to-GPR54 pathway and being suppressed by BMP-4-to-Smad1/5/8 17 
signaling (Fig. 5).  18 
Our results showing that estrogen acts directly on GT1-7 neurons to 19 
suppress GnRH expression as well as to enhance the GPR54 pathway have 20 
added more complexity to the system for gonadotropin regulation.  Estrogen 21 
also has been shown to regulate kiss1 mRNA differentially in various nuclei that 22 
exert major physiological activity in the forebrain (Jacobi et al., 2007).  Estrogen 23 
stimulation promotes kiss1 expression in the ventromedial hypothalamus AVPV, 24 
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which is implicated in positive feedback regulation of the luteinizing hormone 1 
(LH) surge, whereas it reduces kiss1 expression in the ARC, which is implicated 2 
in negative feedback regulation of GnRH in female reproduction (Smith et al., 3 
2005).  In the present study, a mutual interaction of the expression control of 4 
ERs and GPR54 was shown by GT1-7 cells, in which both ER and ER 5 
mRNAs were increased by kisspeptin, while GPR54 expression and the 6 
GPR54-induced ERK1/2 signaling were enhanced by estradiol.  Expression of 7 
ER in GnRH neurons is not clearly demonstrated, but GnRH neurons do 8 
express ER and the estrogen membrane receptor GPR30 (Kenealy et al., 9 
2011; Terasawa and Kenealy, 2012).  It was also reported that estrogen elicited 10 
circadian profiles of GPR54 expression in vitro possibly through ER action 11 
(Tonsfeldt et al., 2011).  The upregulation of GRP54 was likely involved in the 12 
stimulation of estradiol-induced GnRH secretion as a positive feedback induced 13 
by estrogen (Tonsfeldt et al., 2011).  These results suggest that sensitivity of 14 
GnRH secretion to kisspeptin is partly dependent on estrogen activity.  Elevated 15 
gonadal estrogen level may increase kisspeptinergic tone at the same time as 16 
increasing GnRH neuronal sensitivity.   17 
Interestingly, effects of kisspeptin on GnRH induction were suppressed 18 
by co-treatment with BMPs, with BMP-4 action effectively suppressing induction 19 
of GnRH expression by kisspeptin (Fig. 5).  A complex interaction of neural and 20 
hormonal signals including BMPs and kisspeptin may integrate the neuronal 21 
activity for GnRH secretion.  The neuroregulatory factor TGF-1 secreted by 22 
astrocytes is a putative candidate for modulation of GnRH secretion (Buchanan 23 
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et al., 2000; Galbiati et al., 1996; Melcangi et al., 1995; Zwain et al., 2002).  A 1 
regulatory role of TGF- originating from astrocytes in GnRH release has also 2 
been demonstrated (Ma et al., 1992; Ma et al., 1997; Ojeda et al., 2000).  In the 3 
present study, expression of the BMP system including BMP ligands and key 4 
receptors was shown in the hypothalamus.  Given the findings that several 5 
BMPs elicit a neurotropic capacity for dopaminergic neurons in cooperation with 6 
other members of the TGF- superfamily through glial cells (Jordan et al., 1997; 7 
Reiriz et al., 1999; Samanta et al., 2007), hypothalamic GnRH synthesis may be 8 
functionally associated with BMP activity in a neural network in the 9 
hypothalamus.   10 
The BMP system has been shown to play critical roles in initial 11 
development of the anterior pituitary (Scully and Rosenfeld, 2002), and BMPs 12 
modulate GnRH responses in gonadotropes (Takeda et al., 2012).  BMP-4 is 13 
necessary for the first step of pituitary organogenesis including the proliferation 14 
of Rathke’s pouch, which gives rise to Pit-1 lineage cells.  BMP-4 not only 15 
governs pituitary organogenesis but also plays a role in the pathogenesis of 16 
differentiated pituitary lineages (Otsuka et al., 2012; Tsukamoto et al., 2010).  17 
The BMP system also acts as a key molecule in the early developmental stages 18 
of the hypothalamus in the neural tube in conjunction with hedgehog activity 19 
(Liu and Niswander, 2005; Ulloa and Briscoe, 2007).  Hypothalamic neuronal 20 
differentiation is regulated by a series of activities induced by sonic hedgehog 21 
(Shh) and BMP-7 via specification of hypothalamic progenitors (Ohyama et al., 22 
2008).  The elaborate neural patterning seems to be achieved by integrated 23 
antagonism between Shh and BMP actions.  In addition, it was recently 24 
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reported that BMP type IB receptor (ALK-3) signaling is critical for postnatal 1 
establishment of the hypothalamic circuit from ARC to multiple nuclei, which 2 
regulate energy homeostasis and feeding behavior (Peng et al., 2012).  3 
The receptors for TGF- superfamily members consist of type I and type 4 
II receptors, each of which exhibits Ser/Thr kinase activity.  Among the several 5 
combinations of BMP ligands and receptors, BMP-4 readily binds to ALK-3 6 
and/or ALK-6 and preferentially binds to BMPRII (Shimasaki et al., 2004).  7 
Since ALK-6 is not expressed in GT1-7 cells (Otani et al., 2009), the receptor 8 
pairs of ALK-3/BMPRII are likely to be the major functional complex for BMP-4.  9 
Our data demonstrated that kisspeptin suppressed BMP-Smad1/5/8 signaling 10 
by augmenting the expression of inhibitory Smad6 and/or Smad7 in GT1-7 cells.  11 
The expression of GPR54 mRNA was potently suppressed by BMPs, and the 12 
suppressive effects of BMPs on GnRH expression were reversed in the 13 
presence of kisspeptin.  It was also revealed that BMP-4-activated Smad1/5/8 14 
phosphorylation and Id-1 expression were suppressed by kisspeptin-induced 15 
increase of inhibitory Smad6/7.  Smad6/7 expression was increased by 16 
kisspeptin, particularly in the presence of BMP-4.  This new interaction between 17 
the BMP-Smad pathway and kisspeptin-GPR54 signaling may be involved in 18 
the control of GnRH-neuronal activity. 19 
The neuronal mechanism through which estrogen regulates GnRH 20 
neurons is a key for elucidating reproductive control of the HPO axis.  In our 21 
study, kisspeptin stimulated MAPKs and AKT signaling, particularly in the 22 
presence of estrogen, in which ERK1/2 signaling was functionally involved in 23 
the kisspeptin-induced GnRH expression.  It was also revealed that BMP-4 24 
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suppressed kisspeptin-induced GnRH expression by reducing ERK signaling 1 
activity.  There have been several reports on signaling of kisspeptin for GnRH 2 
release.  The pulsatile pattern of GnRH release, which results in the intermittent 3 
release of gonadotropins from the pituitary, is critical for maintenance of 4 
reproductive function.  Ozcan et al. revealed the pattern of kisspeptin-induced 5 
intracellular signaling and the role of protein kinase C (PKC) in the intracellular 6 
signaling cascade by fluorescence calcium imaging using GT1-7 cells (Ozcan et 7 
al., 2011), and their results suggested the importance of intracellular calcium 8 
flux downstream from GPR54 through the PKC signaling pathway.  Novaira et 9 
al. reported an interesting finding that the negative regulation of GnRH secretion 10 
by estrogen was antagonized by kisspeptin (Novaira et al., 2009).  In our study, 11 
GnRH response to kisspeptin was weaker than the previous reports (Novaira et 12 
al., 2009; Tonsfeldt et al., 2011).  This could be due to the culture condition with 13 
serum-free medium for 24 h in our experiments, although this condition was 14 
chosen to simplify the interaction between BMP and a genomic effect of ER.  15 
Much earlier time points and serum inclusion might be suitable to see higher 16 
responsiveness of GnRH.  Further approaches to the intracellular signaling 17 
pathway revealed the involvement of ERK1/2 and phosphatidylinositol-3-kinase 18 
(PI3K)-AKT pathways in the effects of kisspeptin on GnRH regulation (Novaira 19 
et al., 2009).  This work demonstrated that the kisspeptin-GPR54 system plays 20 
a role not only in stimulating GnRH secretion but also in positive regulation of 21 
GnRH mRNA levels via MAPK and AKT signaling in hypothalamic neurons.  22 
Taken together, both MAPK and AKT pathways seem to be substantially linked 23 
to the activation of GnRH regulation by kisspeptin and estrogen.  24 
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Collectively, the results indicate that the axis of kisspeptin-induced GnRH 1 
production was positively controlled by an interaction between ER/ and 2 
GPR54 and, on the other hand, negatively regulated by BMP-4 signaling in 3 
GT1-7 cells (Fig. 5).  Considering that GT1-7 cells exhibit daily changes in 4 
cellular peptide expression and GnRH secretion in response to kisspeptin and 5 
other hormones (Zhao and Kriegsfeld, 2009), the regulatory mechanism of 6 
GnRH modulated by intrinsic circadian cycles may also be taken account for 7 
approaching the role in the reproductive axis.  However, we cannot fully 8 
translate this interaction shown in a GT1-7 cell model into the physiological 9 
situation in vivo because of the lack of ER in native GnRH neurons (Herbison 10 
and Pape, 2001; Herbison, 2008).  Given that kisspeptin neurons predominantly 11 
express ER with a modest fraction expressing ER (Pinilla et al., 2012), it can 12 
be postulated that kisspeptin neurons are also involved in the regulatory 13 
mechanism of estrogen for GnRH secretion in the presence of BMP-4.  Further 14 
studies on the molecular mechanism are needed to elucidate the detailed 15 
mechanism of hypothalamic release of GnRH and the in vivo role of the BMP 16 
system in the physiologic gonadotropin surge and onset of puberty.  A mutual 17 
interaction of kisspeptin, estrogen and BMP-4 may be a key for fine-tuning of 18 
GnRH regulation under the dynamic influence of estrogen level. 19 
 20 
 21 
 22 
  23 
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FIGURE LEGENDS 1 
 2 
Fig. 1. Expression of kisspeptin system and kisspeptin actions on GnRH 3 
production by GT1-7 cells.  A) Total cellular RNAs were extracted from GT1-7 4 
cells.  The expression of GnRH (247 bp), kiss1 (392 bp), GPR54 (186 bp), ER 5 
(235 bp), ER (324 bp) and the housekeeping gene RPL19 (195 bp) in GT1-7 6 
cells was examined by RT-PCR.  Aliquots of PCR products were 7 
electrophoresed on 1.5% agarose gel and visualized by ethidium bromide 8 
staining, and the results shown are representative of those obtained from three 9 
independent experiments.  MM indicates molecular weight marker.  B) The 10 
expression of GnRH, kiss1, GPR54, ER, ER, BMP ligands including BMP-2 11 
(212 bp), -4 (241 bp), -6 (224 bp) and -7 (287 bp), BMP receptors including 12 
ALK-2 (483 bp), -3 (510 bp), -4 (528 bp), -6 (456 bp), BMPRII (522 bp), ActRIIA 13 
(492 bp) and ActRIIB (271 bp), and Smad6 (165 bp) and Smad 7 (169 bp) in the 14 
mouse hypothalamus was also examined by RT-PCR.  C) GT1-7 cells (2  105 15 
cells/ml) were treated with indicated concentrations of kisspeptin in serum-free 16 
conditions.  After 24-h culture, the culture media were collected and GnRH 17 
concentrations (pg/ml) were determined by a radioimmunoassay.  D, E) Cells (2 18 
 105 cells/ml) were treated with indicated concentrations of kisspeptin in 19 
serum-free conditions for 24 h.  Total cellular RNA was extracted and mRNA 20 
levels of GnRH, kiss1 and GPR54 were examined by real-time RT-PCR.  The 21 
expression levels of target genes were standardized by RPL19 level in each 22 
sample.  Results in all panels are shown as means ± SEM of data from at least 23 
three separate experiments, each performed with triplicate samples.  The 24 
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results were analyzed by ANOVA (C-E) and, when a significant effect due to 1 
treatment was observed, subsequent comparisons of group means were 2 
conducted.  For each result within a panel, the values with different superscript 3 
letters are significantly different at P < 0.05.  *, P < 0.05 vs. control group.  4 
 5 
Fig. 2. Kisspeptin and BMP actions on GnRH and GPR54 expression by 6 
GT1-7 cells.  GT1-7 cells (2  105 cells/ml) were treated with indicated 7 
concentrations of kisspeptin (300 nM) in combination with BMP-2, -4, -6 and -7 8 
(100 ng/ml) in serum-free conditions for 24 h.  Total cellular RNA was extracted 9 
and (A) GnRH and (B) GPR54 mRNA levels were examined by real-time RT-10 
PCR.  The expression levels of target genes were standardized by RPL19 level 11 
in each sample.  Results in all panels are shown as means ± SEM of data from 12 
at least three separate experiments, each performed with triplicate samples.  13 
The results were analyzed by ANOVA and unpaired t-test and, when a 14 
significant effect due to treatment was observed (P < 0.05), subsequent 15 
comparisons of group means were conducted.  *, P < 0.05 and **, P < 0.01 16 
between the indicated groups;  #, P < 0.05 vs. control group.  n.s., not 17 
significant. 18 
 19 
Fig. 3. Effects of kisspeptin on BMP-Smad signaling in GT1-7 cells.  A) 20 
GT1-7 cells (1  105 cells/ml) were precultured in serum-free conditions in the 21 
absence or presence of kisspeptin (300 nM) for 24 h, and then stimulated with 22 
BMP-2 and -4 (100 ng/ml).  After 60-min culture with BMP treatment, cells were 23 
lysed and subjected to SDS-PAGE/immunoblotting (IB) analysis using anti-24 
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phospho-Smad1/5/8 (pSmad1/5/8) and anti-actin antibodies.  The results shown 1 
are representative of those obtained from three independent experiments.  B) 2 
Cells (2  105 cells/ml) were treated with BMP-2, -4, -6 and -7 (100 ng/ml) in 3 
combination with kisspeptin (300 nM) in serum-free conditions for 24 h.  Total 4 
cellular RNA was extracted and Id-1 mRNA level was examined by real-time 5 
RT-PCR.  The expression levels of target genes were standardized by RPL19 6 
level in each sample.  C) Cells (2  105 cells/ml) were treated with kisspepetin 7 
(300 nM) in combination with estradiol (100 nM) in serum-free conditions for 24 8 
h.  Total cellular RNA was extracted and ALK-3 and BMPRII mRNA levels were 9 
examined by real-time RT-PCR.  D) Cells were treated with kisspeptin (300 nM) 10 
in the presence of BMP-2 and -4 (100 ng/ml) in serum-free conditions for 24 h.  11 
Total cellular RNA was extracted and Smad6 and Smad7 mRNA levels were 12 
examined by real-time RT-PCR.  Results in all panels are shown as means ± 13 
SEM of data from at least three separate experiments, each performed with 14 
triplicate samples.  The results were analyzed by ANOVA and, when a 15 
significant effect due to treatment was observed (P < 0.05), subsequent 16 
comparisons of group means were conducted.  #, P < 0.05 vs. control group; 17 
and *, P < 0.05 between the indicated groups.   18 
 19 
Fig. 4. Interaction of kisspeptin and estrogen receptor signaling in GnRH 20 
induction by GT1-7 cells.  A, B) GT1-7 cells (2  105 cells/ml) were treated 21 
with kisspeptin (10 to 100 nM) and estradiol (100 nM) in serum-free conditions 22 
for 24 h.  Total cellular RNA was extracted and ER, ER, GnRH and GPR54 23 
mRNA levels were examined by real-time RT-PCR.  The expression levels of 24 
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target genes were standardized by RPL19 level in each sample.  C) Cells (2  1 
105 cells/ml) were treated with indicated concentrations of estradiol in serum-2 
free conditions.  After 24-h and 48-h culture, the culture media were collected 3 
and GnRH concentrations (pg/ml) were determined by a radioimmunoassay.  D, 4 
F) Cells (1  105 cells/ml) were precultured in serum-free conditions in the 5 
absence or presence of estradiol (E2; 100 nM) and BMP-4 (100 ng/ml) for 24 h, 6 
and then stimulated with kisspeptin (Kp; 300 nM).  After 15-min culture with 7 
kisspeptin treatment, cells were lysed and subjected to SDS-8 
PAGE/immunoblotting (IB) analysis using anti-phospho-ERK1/2 (pERK) and 9 
anti-total-ERK1/2 (tERK), and anti-phospho-AKT (pAKT) and anti-total-AKT 10 
(tAKT), anti-phospho-JNK (pJNK) and anti-total JNK (tJNK), and anti-phospho-11 
p38 (pP38) and anti-total-p38 (tP38) antibodies.  The results shown are 12 
representative of those obtained from three independent experiments.  The 13 
relative integrated density of each protein band was digitized, in which the 14 
phosphorylated levels were normalized by the total levels, and then the results 15 
were expressed as fold changes.  E) Cells (2  105 cells/ml) were treated with 16 
MAPK and AKT inhibitors (1 to 10 M), including U0126 (U01), SB203580 17 
(SB20), SP600125 (SP600) and SH-5 (SH5), in combination with kisspeptin 18 
(300 nM) in serum-free conditions for 24 h.  Total cellular RNA was extracted 19 
and GnRH mRNA levels were examined by real-time RT-PCR.  Results in all 20 
panels are shown as means ± SEM of data from at least three separate 21 
experiments, each performed with triplicate samples.  The results were 22 
analyzed by ANOVA (A, D-F) and unpaired t-test (B, C) and when a significant 23 
effect due to treatment was observed (P < 0.05), subsequent comparisons of 24 
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group means were conducted.  *, P < 0.05 and **, P < 0.01 vs. control group 1 
and between the indicated groups.   2 
 3 
Fig. 5. Interaction of kisspeptin, estrogen and BMP-4 in regulation of 4 
GnRH production by GT1-7 cells.  Kisspeptin stimulates GnRH production via 5 
GPR54 and its downstream signaling of the ERK pathway in GT1-7 cells.  6 
Estrogen upregulates GPR54 expression, while kisspeptin increases the 7 
expression levels of ER/, suggesting that the actions of estrogen and 8 
kisspeptin are mutually enhanced.  Kisspeptin effects on GnRH induction were 9 
suppressed by BMP-4, by inhibiting ERK phosphorylation and GPR54 10 
expression.  On the other hand, by upregulating inhibitory Smads6/7, kisspeptin 11 
suppressed Smad1/5/8 phosphorylation and Id-1 expression induced by BMP-4 12 
through the ALK-3/BMPRII receptor.  In GT1-7 neuron cells, the axis of 13 
kisspeptin-induced GnRH production is augmented by an interaction between 14 
ER/ and GPR54 and it is also negatively controlled by BMP-4.  15 
 16 
 17 
 Title: 
Mutual interaction of kisspeptin, estrogen and bone morphogenetic 
protein-4 activity in GnRH regulation by GT1-7 cells. 
  
Authors: 
Tomohiro Terasaka, Fumio Otsuka, et al. 
 
Highlight: 
 Kisspeptin and estrogen mutually enhanced the expression of ERs and 
GPR54 in GT1-7 cells. 
 
 Kisspeptin increased GnRH production by ERK activation, which was 
suppressed by BMP-4. 
 
 GPR54 expression was reduced by BMP-4, while BMP-Smad signaling was 
inhibited via kisspeptin-induced Smad6/7. 
 
 Under the influence of estrogen, the interaction of kisspeptin and BMP-4 is a 
key for fine-tuning of GnRH level. 
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